Скачать или смотреть Side-effects of GLP-1 RAs

We spoke to Deborah Evans about GLP-1 receptor agonists – the fat jabs – and what we have learned over the past 12-18 months.

Read, watch and listen here - https://medicalupdateonline.com/2025/...

___

Keep up to date with us across our network;

Email us at - [email protected]
Site - https://medicalupdateonline.com/
Twitter -   / medupdateon1ine  
Instagram -   / medicalupdateonline  
Facebook -   / medupdateonline  
LinkedIn -   / medicalupdateonline  

This content is for informational purposes only, and does not replace the advice of your own doctor or healthcare professional. Copyright © 2022 MedicalUpdateOnline.

IMI (a trading name of ICR UK Limited) is a digital communications agency that specialises in the pharmaceutical and medical industries.

IMI was founded in 2003 by the current CEO Peter Mas-Mollinedo, a pharmacist and forward-thinking entrepreneur. IMI’s primary activities include the production of medical educational journals and bulletins, medical conference coverage and video interviewing of health care professionals worldwide to disseminate information such as trial results, new products, research, drug approvals, new accreditations, etc.

It is a trusted provider of medical information to its extensive database of medical health care professionals in the UK, Europe and beyond.

To find out more about IMI, please see our websites www.medicalupdateonline.com and www.medicalimi.com. Alternatively, you can email us at [email protected].